Latest News

Upcoming Events

GenmabTech news archive

December 2015

Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen
 
Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen

October 2015

Genmab Achieves $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

Genmab Reaches $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

August 2015

Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody® Technology

July 2015

Genmab's successful DuoBody® technology collaboration with Janssen

May 2015

Genmab Enters Commercial DuoBody® Technology Agreement with BioNTech in Field of Immuno-oncology
 
Apply for an Open Innovation Grant from Genmab

February 2015

Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology 

December 2014

Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

September 2014

Nature Protocols publishes DuoBody technology paper

July 2014

Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen

June 2014

Genmab Announces DuoBody and HexaBody Platform Collaboration with Undisclosed Biotechnology Company
 
Presentation on bispecific IgG1-Her2xCD3 at the Empowered Antibody Congress 2014

May 2014

Genmab Opens Door for Open Innovation

Presentation on bispecific IgG1-Her2xCD3 at PEGS 2014

March 2014

Presentation on IgG4 biology and the DuoBody platform at ATT 2014

The biology of antibody hexamerization published in Science

January 2014

Genmab Announces DuoBody Platform Collaboration with Lilly
 
Presentation on the DuoBody platform at Peptalk 2014

December 2013

Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen — Financial Guidance Improved
 
Genmab Announces Expansion of DuoBody Platform Collaboration with Janssen Biotech, Inc

November 2013

Dr Parren and Dr Schuurman headed roundtable discussions
 
DuoBody data presented at three conferences

Genmab at partnering conference

September 2013

Janssen presented DuoBody manufacturability data at the 4th Bispecific Antibody Summit 2013

Novel DuoBody data, focusing on CD3-bispecifics, presented at the 4th Bispecific Antibody Summit 2013

August 2013

Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen

June 2013

DuoBody was presented at the 30th conference on monoclonal antibodies and cancer stem cells 

April 2013

DuoBody was presented at PEGS, 2-3 May 2013

December 2012

Genmab Unveils A New Antibody Technology Platform: HexaBody

Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen

July 2012

Genmab Enters Broad Collaboration with Janssen Biotech, Inc. for DuoBody Platform

June 2012

Genmab Enters DuoBody Technology Collaboration With Novartis

December 2011

Genmab Announces Progress with DuoBody® Platform